Cronos Expands Medical Cannabis Presence in Switzerland

LOS ANGELES- Cronos Group Inc. has entered the Swiss medical cannabis market through a partnership with Dascoli Pharma AG, a Zurich-based pharmaceutical distributor. The deal enables Dascoli to supply five varieties of the company’s PEACE NATURALS branded cannabis flower to patients via its established network of pharmacies and clinics.

Under the agreement, the following strains will be available in Switzerland:

• GMO Cookies

• Space Cake

• Atomic Sour Grapefruit

• Sonic Lemon Fuel

• Wedding Cake.

This launch marks Switzerland as the latest addition to Cronos’ European footprint, alongside markets such as Australia, Canada, Germany, Israel, Malta and the UK. Cronos CEO Mike Gorenstein stated the partnership “aligns with our mission to provide borderless cannabis products to European medical markets”.

From a business standpoint, this deal supports Cronos’ strategy of international expansion through local partnerships. By collaborating with Dascoli—a company experienced in rapid, next‑day delivery of cannabis therapies—Cronos can reduce market-entry costs and accelerate reach into Swiss patients.

For Dascoli, the agreement enhances its product portfolio with a globally recognized brand backed by Cronos. Observers note that expanding access to regulated medical cannabis can reinforce Switzerland’s pharmaceutical infrastructure and deepen its role in Europe’s medical cannabis supply chain .

Swiss market expansion also aligns with broader global trends prompting cannabis companies to diversify revenue streams outside North America. In Toronto, Cronos is positioned among other major global cannabinoid firms leveraging research, intellectual property and multi-market reach—moving away from price‑sensitive commodity markets, as evidenced by its varied brand strategy alongside Spinach and Lord Jones